CIBC World Markets’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,421
Closed -$365K 1682
2025
Q1
$365K Buy
8,421
+60
+0.7% +$3.04K ﹤0.01% 1164
2024
Q4
$470K Sell
8,361
-2,392
-22% -$149K ﹤0.01% 753
2024
Q3
$732K Buy
10,753
+965
+10% +$54.5K 0.01% 643
2024
Q2
$414K Buy
9,788
+2,384
+32% +$131K ﹤0.01% 673
2024
Q1
$511K Buy
7,404
+2,371
+47% +$150K ﹤0.01% 718
2023
Q4
$372K Buy
+5,033
New +$330K ﹤0.01% 680
2015
Q1
Sell
-109,100
Closed -$2.99M 75
2014
Q4
$2.99M Buy
+109,100
New +$2.66M 0.15% 51

Other funds holding EXAS

CIBC World Markets's EXAS Position: Q2 2025 in Review

CIBC World Markets sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 8,421 shares — an estimated $365K sold.

CIBC World Markets first reported a position in EXAS in Q4 2014 and held it in 7 quarters. The position peaked at $2.99M in Q4 2014. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • CIBC World Markets reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • CIBC World Markets sold 8,421 Exact Sciences shares in Q2 2025, an estimated $365K.
  • CIBC World Markets first reported a position in Exact Sciences in Q4 2014 and held it in 7 quarters.
  • CIBC World Markets's Exact Sciences position peaked at $2.99M in Q4 2014.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.